Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance

Science

Volumn 287, Issue 5457, 2000, Pages 1479-1482

  Bjorkman J ^a   Nagaev, I ^a   Berg, O G ^a   Hughes, D ^a   Andersson, D I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FUSIDIC ACID; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; CULTURE MEDIUM; ENVIRONMENT; EVOLUTION; EXPERIMENTAL MOUSE; GENE MUTATION; GENETIC SELECTION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPORTERS; CARRIER PROTEINS; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI PROTEINS; EVOLUTION, MOLECULAR; FEMALE; FUSIDIC ACID; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MUTATION; PEPTIDE ELONGATION FACTOR G; RIBOSOMAL PROTEINS; SALMONELLA TYPHIMURIUM; SELECTION (GENETICS); SERIAL PASSAGE; STREPTOMYCIN; SUPPRESSION, GENETIC;

BACTERIA (MICROORGANISMS); SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0042373060     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.287.5457.1479     Document Type: Article

References (31)

1. J. B. McCormick, Curr. Opin. Microbiol. 1, 125 (1999); B. R. Levin et al., Clin. Infect. Dis. 24, S9 (1997); D. J. Austin, K. G. Kristinsson, R. M. Anderson, Proc. Natl. Acad. Sci. U.S.A. 96, 1152 (1999).
2. J. B. McCormick, Curr. Opin. Microbiol. 1, 125 (1999); B. R. Levin et al., Clin. Infect. Dis. 24, S9 (1997); D. J. Austin, K. G. Kristinsson, R. M. Anderson, Proc. Natl. Acad. Sci. U.S.A. 96, 1152 (1999).
3. J. B. McCormick, Curr. Opin. Microbiol. 1, 125 (1999); B. R. Levin et al., Clin. Infect. Dis. 24, S9 (1997); D. J. Austin, K. G. Kristinsson, R. M. Anderson, Proc. Natl. Acad. Sci. U.S.A. 96, 1152 (1999).
4. D. I. Andersson and B. R. Levin, Curr. Opin. Microbiol. 2, 487 (1999).
5. J. Bjôrkman, D. Hughes, D. I. Andersson, Proc. Natl. Acad. Sci. U.S.A. 95, 3949 (1998); R. I. Modi and J. Adams, Evolution 45, 656 (1991); S. Schrag and V. Perrot, Nature 381, 120 (1996); R. E. Lenski, S. C. Simpson, T. T. Nguyen, J. Bacteriol. 176, 3140 (1994); B. R. Levin, V. Perrot, N. M. Walker, Genetics, in press; D. R. Sherman et al., Science 272, 1641 (1996); P. J. McDermott, P. Gowland, P. C. Gowland, Lett. Appl. Microbiol. 17, 139 (1993).
6. J. Bjôrkman, D. Hughes, D. I. Andersson, Proc. Natl. Acad. Sci. U.S.A. 95, 3949 (1998); R. I. Modi and J. Adams, Evolution 45, 656 (1991); S. Schrag and V. Perrot, Nature 381, 120 (1996); R. E. Lenski, S. C. Simpson, T. T. Nguyen, J. Bacteriol. 176, 3140 (1994); B. R. Levin, V. Perrot, N. M. Walker, Genetics, in press; D. R. Sherman et al., Science 272, 1641 (1996); P. J. McDermott, P. Gowland, P. C. Gowland, Lett. Appl. Microbiol. 17, 139 (1993).
7. J. Bjôrkman, D. Hughes, D. I. Andersson, Proc. Natl. Acad. Sci. U.S.A. 95, 3949 (1998); R. I. Modi and J. Adams, Evolution 45, 656 (1991); S. Schrag and V. Perrot, Nature 381, 120 (1996); R. E. Lenski, S. C. Simpson, T. T. Nguyen, J. Bacteriol. 176, 3140 (1994); B. R. Levin, V. Perrot, N. M. Walker, Genetics, in press; D. R. Sherman et al., Science 272, 1641 (1996); P. J. McDermott, P. Gowland, P. C. Gowland, Lett. Appl. Microbiol. 17, 139 (1993).
8. J. Bjôrkman, D. Hughes, D. I. Andersson, Proc. Natl. Acad. Sci. U.S.A. 95, 3949 (1998); R. I. Modi and J. Adams, Evolution 45, 656 (1991); S. Schrag and V. Perrot, Nature 381, 120 (1996); R. E. Lenski, S. C. Simpson, T. T. Nguyen, J. Bacteriol. 176, 3140 (1994); B. R. Levin, V. Perrot, N. M. Walker, Genetics, in press; D. R. Sherman et al., Science 272, 1641 (1996); P. J. McDermott, P. Gowland, P. C. Gowland, Lett. Appl. Microbiol. 17, 139 (1993).
9. J. Bjôrkman, D. Hughes, D. I. Andersson, Proc. Natl. Acad. Sci. U.S.A. 95, 3949 (1998); R. I. Modi and J. Adams, Evolution 45, 656 (1991); S. Schrag and V. Perrot, Nature 381, 120 (1996); R. E. Lenski, S. C. Simpson, T. T. Nguyen, J. Bacteriol. 176, 3140 (1994); B. R. Levin, V. Perrot, N. M. Walker, Genetics, in press; D. R. Sherman et al., Science 272, 1641 (1996); P. J. McDermott, P. Gowland, P. C. Gowland, Lett. Appl. Microbiol. 17, 139 (1993).
10. J. Bjôrkman, D. Hughes, D. I. Andersson, Proc. Natl. Acad. Sci. U.S.A. 95, 3949 (1998); R. I. Modi and J. Adams, Evolution 45, 656 (1991); S. Schrag and V. Perrot, Nature 381, 120 (1996); R. E. Lenski, S. C. Simpson, T. T. Nguyen, J. Bacteriol. 176, 3140 (1994); B. R. Levin, V. Perrot, N. M. Walker, Genetics, in press; D. R. Sherman et al., Science 272, 1641 (1996); P. J. McDermott, P. Gowland, P. C. Gowland, Lett. Appl. Microbiol. 17, 139 (1993).
11. J. Bjôrkman, D. Hughes, D. I. Andersson, Proc. Natl. Acad. Sci. U.S.A. 95, 3949 (1998); R. I. Modi and J. Adams, Evolution 45, 656 (1991); S. Schrag and V. Perrot, Nature 381, 120 (1996); R. E. Lenski, S. C. Simpson, T. T. Nguyen, J. Bacteriol. 176, 3140 (1994); B. R. Levin, V. Perrot, N. M. Walker, Genetics, in press; D. R. Sherman et al., Science 272, 1641 (1996); P. J. McDermott, P. Gowland, P. C. Gowland, Lett. Appl. Microbiol. 17, 139 (1993).
12. J. Bjôrkman, P. Samuelsson, D. I. Andersson, D. Hughes, Mol. Microbiol. 31, 53 (1999).
13. C. G. Kurland, D. Hughes, M. Ehrenberg, in Escherichia coli and Salmonella: Cellular and Molecular Biology, F. C. Neidhardt, Ed. [American Society for Microbiology (ASM) Press, Washington, DC, 1996], pp. 979-1004.
14. U. Johansson, A. Evarsson, A. Liljas, D. Hughes, J. Mol. Biol. 258, 420 (1996); T. Ruusala, D. I. Andersson, M. Ehrenberg, C. G. Kurland, EMBO J. 3, 2575 (1984); K. Bohman, T. Ruusala, P. C. Jelenc, C. G. Kurland, Mol. Gen. Genet. 198, 90 (1984).
15. U. Johansson, A. Evarsson, A. Liljas, D. Hughes, J. Mol. Biol. 258, 420 (1996); T. Ruusala, D. I. Andersson, M. Ehrenberg, C. G. Kurland, EMBO J. 3, 2575 (1984); K. Bohman, T. Ruusala, P. C. Jelenc, C. G. Kurland, Mol. Gen. Genet. 198, 90 (1984).
16. U. Johansson, A. Evarsson, A. Liljas, D. Hughes, J. Mol. Biol. 258, 420 (1996); T. Ruusala, D. I. Andersson, M. Ehrenberg, C. G. Kurland, EMBO J. 3, 2575 (1984); K. Bohman, T. Ruusala, P. C. Jelenc, C. G. Kurland, Mol. Gen. Genet. 198, 90 (1984).
17. 6 bacteria were injected, and after 3 to 4 days ∼109 bacteria were recovered, resulting in 10 generations of growth.
18. The sequences of the relevant genes were determined as previously described (4, 6). For each of the FusR-compensated mutants, the fusA gene was sequenced, and for each of the SmR-compensated mutants, the sequences of the rpsD, rpsE, and rpsL genes were determined. To confirm that the compensatory mutations identified by sequencing conferred compensation, they were transferred to a new genetic background by transduction using linked Tn10 elements.
19. M. Macvanin, U. Johanson, M. Ehrenberg, D. Hughes, Mol. Microbiol., in press.
20. M. Cashel, D. R. Gentry, V. J, Hernandez, D. Vinella, in Escherichia coli and Salmonella: Cellular and Molecular Biology, F. C. Neidhardt, Ed. (ASM Press, Washington, DC, 1996), pp. 1458-1496.
21. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; C, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and V. Tyr.
22. Supplementary data is available at Science Online at www.sciencemag.org/feature/data/1045726.shl.
23. J. W. Drake, Annu. Rev. Genet. 25, 125 (1991);
24. J. G. de Boer and L. S. Ripley, Proc. Natl. Acad. Sci. U.S.A. 81, 5528 (1984).
25. -7 in the spleen.
26. R. Mikkola and C. C. Kurland, Mol. Biol. Evol. 9, 394 (1992).
27. P. A. Gulig and T. J. Doyle, Infect, Immunol. 61, 504 (1993).
28. J. Torkelson et al., EMBO J. 16, 3303 (1997).
29. R. A. Fisher, The Design of Experiments (Collier Macmiltan, London, 1935).
30. gen (wt) ln(A/B) + tln2], where A is the number of mutant bacteria and B is the number of wild-type bacteria. The relative fitness was calculated as the ratio of the generation time of the wild type divided by the generation time of each individual mutant. The relative fitness of the wild type in mice was set to 1. The generation time of the wild type in LB was 26 min and its relative fitness was set to 1.
31. Supported by the Swedish Medical and Natural Sciences Research Councils, the Swedish Institute for Infectious Disease Control, Lovens Pharmaceutical, and the European Union Biotechnology Research Program.